Opinion|Videos|March 28, 2025
Balancing Effective AD Symptom Control with Long-Term Safety in New Therapies
Author(s)Lisa Swanson, MD, FAAD
Lisa Swanson, MD, FAAD, discusses how to balance the need for effective control of Alzheimer's disease symptoms with concerns about long-term safety, particularly when introducing new therapies.
Advertisement
This news content has been independently developed and is not endorsed by the American Academy of Dermatology.
Video content above is prompted by the following:
- How do you balance the need for effective control of AD symptoms with concerns about long-term safety, particularly when introducing new therapies?
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Related Content
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Harrison Nguyen, MD, MBA, MPH’s Deep Dive into CSU, Vasculitis, and Autoimmune Blisters
2
Day 3 Recap: SDPA Fall 2025
3
From TikTok to Targeted Therapy: Shannon Trotter, DO, on Modern Dermatology Challenges
4
Q&A: Why Oncologist-Dermatologist Collaboration is Essential for Managing Systemic Mastocytosis
5
